I can attest that combining several drugs into a single dosage form van be very challenging, primarily from stability and manufacturing perpsectives. I believe new technology will be required to make this a more routine development exercise. Gilead went through several prototypes for the triple HIV pill before arrivng at something that was commercializable.
Market Data 
Markets 
AI
